BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: €0.18 M
• Last 3 months FTD volume: €0.39 M
• Last year FTD volume: €0.39 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€3.47 M	€65.4 M	🇺🇸 USA
Sarepta Therapeutics SRPT	€0.94 M	€34.64 M	🇺🇸 USA
NanoViricides NNVC	€1.02 M	€2.93 M	🇺🇸 USA
Novavax NVAX	€12.75 M	€0.23 B	🇺🇸 USA
Gilead Sciences GILD	€26.28 M	€0.23 B	🇺🇸 USA
Celldex Therapeutics CLDX	€2.55 M	€6.31 M	🇺🇸 USA
GlaxoSmithKline GSK	€25.51 M	€53.86 M	🇬🇧 UK
Emergent BioSolutions EBS	€1.1 M	€5.09 M	🇺🇸 USA
Cel-Sci CVM	€0.97 M	€5.46 M	🇺🇸 USA